Administration of clomiphene citrate in patients with polycystic ovary syndrome, without inducing withdrawal bleeding, achieves comparable treatment characteristics and outcome

Jacob Farhi, Raoul Orvieto, Roy Homburg

Research output: Contribution to journalArticlepeer-review

Abstract

In an attempt to evaluate the effect of random timing of the start of clomiphene citrate (CC) treatment in anovulatory patients with polycystic ovary syndrome on treatment characteristics and outcome, with no regard to time of menstruation, we studied 291 women in their first CC treatment cycle. Duration of treatment was shorter by 2 days and number of leading follicles was higher when treatment was started late (7-29 days from starting a bleed, as compared with day 5), but no effect of starting day was observed on response rate to CC, maximal E2 level, endometrial thickness, and pregnancy rate.

Original languageEnglish
Pages (from-to)2077-2079
Number of pages3
JournalFertility and Sterility
Volume93
Issue number6
DOIs
StatePublished - Apr 2010

Fingerprint

Dive into the research topics of 'Administration of clomiphene citrate in patients with polycystic ovary syndrome, without inducing withdrawal bleeding, achieves comparable treatment characteristics and outcome'. Together they form a unique fingerprint.

Cite this